While the COVID-19 pandemic hysteria has subsided worldwide, vaccine research and development continue to grab headlines to date. Pandemic darlings Pfizer Inc. (PFE) and Gilead Sciences, Inc. (GILD) have gained significant momentum over the past few years due to their contribution to the fight against the coronavirus and continue to be worth investing due to their robust fundamentals.
The COVID-19 pandemic has significantly impacted the financial market, causing extraordinary volatility and changes in the way stocks are traded. Also, the sky-high inflation and the Fed’s consecutive rate hikes have instilled uncertainty among investors.
